Not convinced we need all of this, can just add a second bullet point noting the recent approval of nirsevimab and that AMBOSS lists it as preferred > palivizumab
Added #deck-AnKing Overhaul for Step 1 & 2-AnKingMed and removed #deck-anking-overhaul-for-step-1–2-ankingmed
Added accepted-suggestion, #deck-AnKing Overhaul for Step 1 & 2-AnKingMed and removed #deck-anking-overhaul-for-step-1–2-ankingmed, open-suggestion